Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B. Coutts, Robert Simister, Peter Bailey et al.|The Lancet|2024Cited by 134
Feasibility of telephone and computerized cognitive testing as a secondary outcome in an acute stroke clinical trial: A mixed methods sub-study of the AcT TrialSajeevan Sujanthan, Pugaliya Puveendrakumaran, Katie N. Dainty et al.|European Stroke Journal|2025Cited by 6
Sex Differences in Outcomes After Tenecteplase for Minor Stroke: A Subanalysis of the TEMPO‐2 TrialAmy Yu, Andrew Micielli, Shabnam Vatanpour et al.|Journal of the American Heart Association|2025Cited by 1